2015 ADAD Family Conference Agenda

<< Return to 2015 Family Conference

Sponsored by the Dominantly Inherited Alzheimer’s Network-Trials Unit (DIAN-TU) and the Alzheimer’s Association

July 18, 2015

Welcome/Introductions

Presentations/Q/A

Genetic Counseling – Meagan Cochran, MS, CGC
Review pre-symptomatic testing and other considerations

Public Policy Engagement on issues facing those with Younger Onset Alzheimer’s Disease (YOAD) – Robert Kramer, MPA

Legal/Financial Matters – Sheri R. Abrams, ESQ
Power of attorney, financial planning, long term care

Concurrent Sessions

• Support for symptomatic family members
• Support for asymptomatic, at-risk family member
• Support for family

Lunch

Introductory Remarks – Randall Bateman, MD

Family Presentations

Research Presentations

Panel Discussions:

State of Alzheimer’s Disease Research – Jeffrey Cummings, MD
DIAN Update – John Morris, MD
DIAN-TU Update – Randall Bateman, MD
NIH Funding and Data Sharing – Neil Buckholtz, PhD

Drug Approval Process and Access
Food and Drug Administration – Janet Woodcock, MD
European Medicines Agency – Maria Isaac, MD
Eli Lilly – Eric Siemers, MD
F. Hoffmann-LaRoche – Robert Lasser, MD, MBA

Closing Remarks

Program Director

Randall J. Bateman, MD is the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine. His research focuses on the causes, and future diagnosis and treatments of Alzheimer’s disease. He has been recognized with awards from the Alzheimer’s Association, Scientific American, the Glenn Award for Aging Research, and the MetLife Medical Research and Promising Investigator Award.

Mailing Address
Washington University, School of Medicine
DIAN-Trials Unit
660 S. Euclid Ave., Campus Box 8111
St. Louis, MO 63110